Locations
San Francisco, CA, USA · Lexington, MA, USA
industry
Biotechnology · DeepTech · Information Technology
Size
11-50 employees
Stage
Series A
founded in
2019
Anagenex is a biotechnology company that leverages AI-driven drug discovery to accelerate the development of new medicines. By testing billions of custom-synthesized compounds and utilizing proprietary neural networks, Anagenex iteratively refines its AI predictions to design and test new compounds at an unprecedented scale. With over 100 billion data points and the ability to conduct experiments on hundreds of millions of compounds in just one month, Anagenex aims to significantly reduce the time it takes to bring new drugs to market, addressing the urgent need for faster solutions in the pharmaceutical industry.
Something looks off?